At the 3rd Department of Health Research (DHR)-ICMR Health Research Excellence Summit, which concluded on 18 November at Bharat Mandapam, New Delhi, ICMR exchanged 20 licensing agreements related to eight technologies with nine Indian companies. With this, the total number of successful technology transfer agreements has increased to 100. This achievement has been achieved in less than two years since the launch of ICMR's flagship initiative, "Medical Innovations Patent Mitra."
Three new initiatives were launched at the summit. DHR's 'Research to Action Vertical' initiative aims to convert research evidence into useful and decision-oriented products that can be used in the formulation and implementation of government policies and health programs. Syndromic Surveillance: Under DHR's Virus Research and Diagnostic Laboratories (VRDL) scheme, an early warning network will be established by linking 70 VRDLs and Infectious Disease Research and Diagnostic Laboratories (IRDLs) to identify disease outbreaks in time. The Dr. M.K. Bhan Young Medical Faculty PhD Portal, launched, will serve as a centralized digital platform for prospective applicants, providing essential information related to the PhD program.
ICMR also released the Antimicrobial Resistance (AMR) Annual Report and Standard Operating Procedures, which brings together the national evidence base on antimicrobial resistance and standardized laboratory procedures. The ICMR Compendium was also released, featuring 25 inspiring stories of how research has been translated into public - use outcomes.